FDA Clearance Tracker · K241724
Cytal® Wound Matrix; Cytal® Burn Matrix
Last checked: Nov 20, 2026Latest source record: Jul 11, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jul 11, 2024
Substantially Equivalent
Time to decision
27 days
Received Jun 14, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Unclassified
The decision
- FDA number
- K241724
- Device name
- Cytal® Wound Matrix; Cytal® Burn Matrix
- Applicant
- Acell, Inc.
- Applicant location
- Columbia, MD
- Received
- Jun 14, 2024
- Decided
- Jul 11, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Unclassified
- Specialty
- General & Plastic SurgeryWound Care
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KGN. The earliest in FDA's data is K790496, decided May 3, 1979.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K241724
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Acell, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241706 · Decided Jul 11, 2024 · 28 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
- MicroMatrix® Flex510(k)
K230980 · Decided Sep 22, 2023 · 170 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
K191734 · Decided Nov 22, 2019 · 147 days after receipt
Device type: Intracardiac Patch Or Pledget, Biologically Derived (PSQ) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.